MétaCan
Menu
Back to cohort
Record W4412764349 · doi:10.1016/j.ijpharm.2025.126014

Inhalable spray-dried nano-in-microparticles encapsulating anandamide: a novel approach for the treatment of asthma

2025· article· en· W4412764349 on OpenAlexfundno aff
Alexandra Hübl, Felix E. B. Brettner, Sarah Vogel‐Kindgen, Florentin Baur, Viktoria Planz, Ralf P. Brandes, Maike Windbergs

Bibliographic record

VenueInternational Journal of Pharmaceutics · 2025
Typearticle
Languageen
FieldMedicine
TopicInhalation and Respiratory Drug Delivery
Canadian institutionsnot available
FundersInnovative Medicines InitiativeBundesministerium für Bildung und ForschungVolkswagen FoundationOntario Institute for Cancer ResearchHessisches Ministerium für Wissenschaft und KunstHorizon 2020 Framework ProgrammeDeutsche Forschungsgemeinschaft
KeywordsAnandamideSpray dryingAsthmaPharmaceutical technologyMicroparticleMedicinePharmacologyNanotechnologyChemistryMaterials scienceChromatographyImmunologyChemical engineeringCannabinoid receptorInternal medicineEngineering

Abstract

fetched live from OpenAlex

-adrenoceptor agonists are widely established as effective therapeutics for asthma treatment, their use can be limited by systemic side effects and the potential for time-dependent desensitization. As a possible alternative, the endocannabinoid anandamide recently gathered attention due to its bronchodilatory effect. However, anandamide exhibits several unfavorable physicochemical properties, in particular strong sensitivity to temperature and light as well as poor aqueous solubility. To overcome these challenges, we developed an inhalable dry powder formulation composed of anandamide-loaded amphiphilic cyclodextrin nanoparticles, co-spray-dried with mannitol as stabilizing excipient. The resulting nano-in-microparticles exhibit a spherical, regular morphology, favorable size (1.24 ± 0.09µm) as well as aerodynamic properties suitable for targeted bronchial application (mass median aerodynamic diameter: 3.63 ± 0.03µm). Compared to pure mannitol particles, the novel carrier system encapsulates an almost three-fold higher drug load. Further physicochemical characterization proved the re-dispersibility and stability of the encapsulated nanocarriers after spray drying. Application onto primary human bronchial cells verified biocompatibility and time-dependent particle uptake of the formulation. pH-dependent intracellular release resulted in highly increased prostaglandin E2 secretion indicating a potential anti-asthmatic effect. In conclusion, the formulation unites drug protection with favorable aerosolization performance for targeted bronchial delivery. Overcoming the obstacle of anandamide degradation, the nano-in-microparticle system offers a novel approach for encapsulation of instable and sensitive drugs bearing great potential for the future treatment of lung diseases.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.000
Threshold uncertainty score0.001

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.387
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of PharmaceuticsSame topicInhalation and Respiratory Drug DeliveryFrench-language works237,207